Climb Bio, Inc. CLYM Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Climb Bio, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Climb Bio, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?
- Climb Bio, Inc. (CLYM) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of $0 in Q1 2026.
- How has Climb Bio, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash changed year-over-year?
- Climb Bio, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash increased by 100.0% year-over-year, from -$24K to $0.